148 related articles for article (PubMed ID: 32784090)
1. Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase.
Keith JM; Jones W; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz M; Scott BP; Wilson SJ; Luo L; Wennerholm M; Chang L; Rizzolio M; Rynberg R; Chaplan S; Guy Breitenbucher J
Bioorg Med Chem Lett; 2020 Oct; 30(20):127463. PubMed ID: 32784090
[TBL] [Abstract][Full Text] [Related]
2. Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase.
Keith JM; Jones WM; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Scott BP; Wilson SJ; Luo L; Wennerholm ML; Chang L; Brown SM; Rizzolio M; Rynberg R; Chaplan SR; Breitenbucher JG
Bioorg Med Chem Lett; 2014 Feb; 24(3):737-41. PubMed ID: 24433863
[TBL] [Abstract][Full Text] [Related]
3. Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites.
Tichenor MS; Keith JM; Jones WM; Pierce JM; Merit J; Hawryluk N; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Wilson SJ; Wennerholm ML; Woestenborghs F; Beerens D; Luo L; Brown SM; Boeck MD; Chaplan SR; Breitenbucher JG
Bioorg Med Chem Lett; 2012 Dec; 22(24):7357-62. PubMed ID: 23141911
[TBL] [Abstract][Full Text] [Related]
4. The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors.
Keith JM; Tichenor MS; Apodaca RL; Xiao W; Jones WM; Seierstad M; Pierce JM; Palmer JA; Webb M; Karbarz MJ; Scott BP; Wilson SJ; Wennerholm ML; Rizzolio M; Rynberg R; Chaplan SR; Breitenbucher JG
Bioorg Med Chem Lett; 2016 Jul; 26(13):3109-3114. PubMed ID: 27189675
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity.
Roughley SD; Browne H; Macias AT; Benwell K; Brooks T; D'Alessandro J; Daniels Z; Dugdale S; Francis G; Gibbons B; Hart T; Haymes T; Kennett G; Lightowler S; Matassova N; Mansell H; Merrett A; Misra A; Padfield A; Parsons R; Pratt R; Robertson A; Simmonite H; Tan K; Walls SB; Wong M
Bioorg Med Chem Lett; 2012 Jan; 22(2):901-6. PubMed ID: 22209458
[TBL] [Abstract][Full Text] [Related]
6. Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH).
Johnson DS; Ahn K; Kesten S; Lazerwith SE; Song Y; Morris M; Fay L; Gregory T; Stiff C; Dunbar JB; Liimatta M; Beidler D; Smith S; Nomanbhoy TK; Cravatt BF
Bioorg Med Chem Lett; 2009 May; 19(10):2865-9. PubMed ID: 19386497
[TBL] [Abstract][Full Text] [Related]
7. Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors.
Gustin DJ; Ma Z; Min X; Li Y; Hedberg C; Guimaraes C; Porter AC; Lindstrom M; Lester-Zeiner D; Xu G; Carlson TJ; Xiao S; Meleza C; Connors R; Wang Z; Kayser F
Bioorg Med Chem Lett; 2011 Apr; 21(8):2492-6. PubMed ID: 21392988
[TBL] [Abstract][Full Text] [Related]
8. 1-Heteroarylpropan-2-ones as inhibitors of fatty acid amide hydrolase: Studies on structure-activity relationships and metabolic stability.
Zahov S; Garzinsky D; Hanekamp W; Lehr M
Bioorg Med Chem; 2017 Feb; 25(3):825-837. PubMed ID: 27989417
[TBL] [Abstract][Full Text] [Related]
9. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
[TBL] [Abstract][Full Text] [Related]
10. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
[TBL] [Abstract][Full Text] [Related]
11. N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.
Sunduru N; Svensson M; Cipriano M; Marwaha S; Andersson CD; Svensson R; Fowler CJ; Elofsson M
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):513-521. PubMed ID: 28114819
[TBL] [Abstract][Full Text] [Related]
12. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors.
Deplano A; Cipriano M; Moraca F; Novellino E; Catalanotti B; Fowler CJ; Onnis V
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):562-576. PubMed ID: 30688118
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain.
Ahn K; Smith SE; Liimatta MB; Beidler D; Sadagopan N; Dudley DT; Young T; Wren P; Zhang Y; Swaney S; Van Becelaere K; Blankman JL; Nomura DK; Bhattachar SN; Stiff C; Nomanbhoy TK; Weerapana E; Johnson DS; Cravatt BF
J Pharmacol Exp Ther; 2011 Jul; 338(1):114-24. PubMed ID: 21505060
[TBL] [Abstract][Full Text] [Related]
14. Novel propanamides as fatty acid amide hydrolase inhibitors.
Deplano A; Morgillo CM; Demurtas M; Björklund E; Cipriano M; Svensson M; Hashemian S; Smaldone G; Pedone E; Luque FJ; Cabiddu MG; Novellino E; Fowler CJ; Catalanotti B; Onnis V
Eur J Med Chem; 2017 Aug; 136():523-542. PubMed ID: 28535469
[TBL] [Abstract][Full Text] [Related]
15. Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors.
Gur Maz T; Turanlı S; Caliskan HB; Çalışkan B; Banoglu E
Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200082. PubMed ID: 35500130
[TBL] [Abstract][Full Text] [Related]
16. Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.
Lamani M; Malamas MS; Farah SI; Shukla VG; Almeida MF; Weerts CM; Anderson J; Wood JT; Farizatto KLG; Bahr BA; Makriyannis A
Bioorg Med Chem; 2019 Dec; 27(23):115096. PubMed ID: 31629610
[TBL] [Abstract][Full Text] [Related]
17. Structure based design of novel irreversible FAAH inhibitors.
Wang JL; Bowen SJ; Schweitzer BA; Madsen HM; McDonald J; Pelc MJ; Tenbrink RE; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2009 Oct; 19(20):5970-4. PubMed ID: 19765986
[TBL] [Abstract][Full Text] [Related]
18. Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas.
Palermo G; Branduardi D; Masetti M; Lodola A; Mor M; Piomelli D; Cavalli A; De Vivo M
J Med Chem; 2011 Oct; 54(19):6612-23. PubMed ID: 21830831
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship studies on 1-heteroaryl-3-phenoxypropan-2-ones acting as inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase: replacement of the activated ketone group by other serine traps.
Sundermann T; Hanekamp W; Lehr M
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):653-63. PubMed ID: 26153239
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
